Product Description

Swisse Ultiboost Zinc+ is a premium quality, comprehensive formula to support healthy immune system function, healthy skin and reproductive health. Zinc is an essential nutrient that the body does not produce by it self. Zinc is a mineral that is essential for the body's normal functions and systems, including the immune system, wound healing, blood clotting, thyroid function, and the senses of taste and smell. Zinc also supports normal growth and development during pregnancy, childhood and adolescence. A healthy supplement is needed to sustain the body ability to regerate. 

Active Ingredients

Each Film Coated Tablet Contains:

Zinc (From Zinc Amino Acid Chelate) 25 mg, Vitamin A (Retinol Acetate) 375 Micrograms/Re, Vitamin B6 (Pyridoxine From Pyridoxine Hydrochloride) 30mg, Magnesium (From Magnesium Phosphate Pentahydrate) 35mg, Manganese (From Manganese Sulfate Monohydrate) 2mg

***No added lactose, gluten, yeast, egg, artificial colours or flavours. Contains soya beans, sulfites & phenylalanine

Directions For Use

Adult Dosage:

One tablet daily, during or after a meal, or as directed by a healthcare professional.

Warning

When taken in excess of 3000 mcg/RE, vitamin A can cause birth defects.

If you are pregnant, or considering becoming pregnant, do not take vitamin A supplements without consulting your doctor or pharmacist.

Vitamins and mineral supplements should not replace a balanced diet.

If symptoms persist, talk to your healthcare professional.

About Swisse

Swisse is an Australian success story. It all began with founder Kevin Ring in a humble Melbourne warehouse in 1969. From the outset, our mission was embedded in the Swisse DNA – a dream to make people all over the world healthier and happier. Today, the Swisse product range stretches from top selling men’s and women’s multivitamins and dietary supplements, to sports nutrition, skincare and functional foods. Swisse products are currently available in Australia, New Zealand, China, Singapore, the UK, Italy and the Netherlands, with plans to launch in up to 30 countries in the next five years.